What were Amanta Healthcare Ltd's latest quarterly results?
Amanta Healthcare Ltd's latest quarterly results (Dec 2025) show
- PAT Growth YoY: +8.2% (stable)
- Revenue Growth YoY: +9.9%
- Operating Margin: 20.6% (volatile)
In Week of Apr 18, 2026, Amanta Healthcare Ltd (Pharmaceuticals Bulk Drugs & Formulation) is outperforming Nifty 500 with +26.7% relative strength.
Weekly presence in the outperformers list. Green = beating Nifty 500 by 10%+ that week.
Revenue, profit and margin growth rates
| Metric | YoY | 3Y CAGR | Trend |
|---|---|---|---|
| Revenue | +10% | +7% | Inflection Up |
| PAT (Net Profit) | +8% | -43% | Stable |
| OPM | 20.6% | -159 bps | Volatile |
Based on publicly available financial data. This is educational research, not investment advice.
Amanta Healthcare Ltd's latest quarterly results (Dec 2025) show
Amanta Healthcare Ltd's profit is growing with an stable trend.
Amanta Healthcare Ltd's revenue growth trend is turning around (inflection up).
Amanta Healthcare Ltd's operating margin is volatile.
Amanta Healthcare Ltd's long-term compounding rates
Amanta Healthcare Ltd's earnings growth is stable with mixed signals on a sequential basis.
Amanta Healthcare Ltd's current PE ratio is 31.6x.
Amanta Healthcare Ltd's price-to-book ratio is 2.4x.
Amanta Healthcare Ltd's fundamental strength based on key financial ratios
Amanta Healthcare Ltd has a debt-to-equity ratio of N/A.
Amanta Healthcare Ltd's return ratios over recent years
Amanta Healthcare Ltd's operating cash flow is positive (FY2025).
Amanta Healthcare Ltd currently does not pay a significant dividend (yield 0.00%).
Amanta Healthcare Ltd's shareholding pattern (Dec 2025)
Amanta Healthcare Ltd's promoter holding has remained stable recently.
Amanta Healthcare Ltd has been outperforming Nifty 500 for 1 consecutive week, indicating early-stage outperformance.
Amanta Healthcare Ltd is a new entry this week — it just started outperforming Nifty 500. New entries are worth monitoring for follow-through.
Based on quantitative research signals, here is why Amanta Healthcare Ltd may be worth studying
Amanta Healthcare Ltd investment thesis summary:
Amanta Healthcare Ltd's forward outlook based on current data signals
The above FAQs are generated from publicly available earnings data and conference call transcripts. This is educational research only. Sector Alpha is not SEBI registered and does not provide investment advice.